MediBeacon's Next Gen TGFRTM System Receives FDA Approval for Kidney Function Assessment

INNOVATE Corp. reports that MediBeacon, a medical technology company in which it owns a 44.7% equity interest, has received FDA approval for its next generation MediBeacon TGFRTM System, including the TGFRTM Reusable Sensor. The TGFR System allows for point-of-care kidney function assessment and will be commercialized in select academic medical centers starting in early 2026.